Table 2.
Characteristics of osteoporosis studies meeting inclusion criteria (n = 9).
| Author | Country | N (Total) |
N (HIV- positive/ HCV- positive) |
Control group (N, Type) |
Sex (% men) |
Age (years) |
Race/ ethnicity (%) |
BMI (kg/m2) |
ART exposure in HIV-positive (%) |
Cirrhosis/ fibrosis (%) |
DXA site |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anastos et al. [28] | USA | 426 | 111 | 162, HIV-positive/HCV-negative | 0 | 41 (mean) | 63 B; 21 W; 16 H | 29 (mean) | 46 (current) | – | Lumbar spine and femoral neck |
| Bonjoch et al. [29]a | Spain | 671 | 208 | 373, HIV-positive/HCV-negative | 72 | 42 (mean) | – | 23 (mean) | 53 (current) | 41 (fibrosis) | Lumbar spine and femoral neck |
| El-Maouche et al. [36] | USA | 179 | 179 | None | 65 | 50 (median) | 85 B | 25 (median) | 89 (ever) | – | Total hip, lumbar spine and femoral neck |
| Lawson-Ayayi et al. [30]a | France | 626 | 208 | 357, HIV-positive/HCV-negative | 74 | 43 (median) | – | 24% (BMI ≤20 kg/m2) | – | 23 (cirrhosis) | Lumbar spine and femoral neck |
| Lo Re III et al. [20]a | Italy | 1237 | 572 | 612, HIV-positive/HCV-negative | 62 | 43 (median) | – | 6% (BMI <18.5 kg/m2); 6% (BMI ≥30 kg/m2) | 79 (current) | – | Lumbar spine and femoral neck |
| Sharma et al. [38] | USA | 389 | 151 | 79, HIV+/HCV− | 100 | 56 (mean) | 58 B; 14 W; 22 H; 6 O | 26 (mean) | 91 (ever) | – | Lumbar spine, femoral neck, and total hip |
| Sharma et al. [31] | USA | 464 | 87 | 158, HIV-positive/HCV-negative | 0 | 48 (mean) | 49 B; 10 W; 26 H; 23 O | 30 (mean) | 88 (ever) | – | Lumbar spine, femoral neck, and total hip |
| Tsai et al. [32]a | Taiwan | 320 | 80 | None | 91 | 37 (median) | – | 10% (BMI <18.5) | 94 (current) | – | Lumbar spine |
| Yin et al. [33] | USA | 187 | 22 | 70, HIV-positive/HCV-negative | 0 | 58 (mean) | 34 AA; 73 H | 29 (mean) | 79 (current) | – | Lumbar spine, femoral neck, total hip, radius |